Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

OBJECTIVES: To compare definitions of high disease activity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in selecting patients for treatment with biologic disease-modifying antirheumatic drugs (bDMARDs). METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Marona, Jose, Sepriano, Alexandre, Rodrigues-Manica, Santiago, Pimentel-Santos, Fernando, Mourão, Ana Filipa, Gouveia, Nélia, Branco, Jaime Cunha, Santos, Helena, Vieira-Sousa, Elsa, Vinagre, Filipe, Tavares-Costa, João, Rovisco, João, Bernardes, Miguel, Madeira, Nathalie, Cruz-Machado, Rita, Roque, Raquel, Silva, Joana Leite, Marques, Mary Lucy, Ferreira, Raquel Miriam, Ramiro, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061099/
https://www.ncbi.nlm.nih.gov/pubmed/32144137
http://dx.doi.org/10.1136/rmdopen-2019-001145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061099/
https://www.ncbi.nlm.nih.gov/pubmed/32144137
http://dx.doi.org/10.1136/rmdopen-2019-001145

Ejemplares similares